WEBCAST ON CD
Sponsored by Medicaid Reimbursement Advisor Weekly
presented on July 19, 2007
Your first look at the Medicaid rebate and AMP final ruling
Listen to ePharmaceuticals for the very first commercial presentation on CMS’ much-anticipated final Medicaid drug rebate rule. This landmark rule was released in July 2007. We will bring you fresh analysis and practical pricing recommendations to help your company respond to the rule’s impact on your products.
“There’s been a lot of chatter about bundling, intercompany transfer pricing, and PBM rebates so the timing of this event is important for companies to assess the impact and adjust,” says Peter Claude of PriceWaterHouseCooper’s pharmaceutical advisory team.
<
In this 90-minue webcast, two expert advisors – Peter Claude and Washington, D.C. attorney John Shakow - will focus on helping you understand the ways in which the final rule builds on – or departs from – the proposed rule issued in December of 2006. They will share practical pricing-related adjustments and discuss legal and policy implications.
At the conclusion of this audioconference, participants will be able to:
- Identify the gaps in the final rule
- Explain the changes from the proposed rule
- Identify required adjustments to pricing calculations
- Comply with the ruling by beginning implementation of changes
Anticipated Agenda
- Medicaid rebate final rule breakdown
- State of the law
- Highlights of final rule and major changes from the proposed rule
- Analysis and impact
- Gaps in the rule (i.e. gray areas and unarticulated items)
- Hot topics:
- Bundling
- Treatment of intercompany transfer price
- Resolution of the safety net provider nominal price exclusion
- PBM rebates – retail class of trade
- Authorized generics
- Other “surprises” from the final rule
- Practical implementation issues
- How to operationalize the changes
- How to make adjustments to pricing calculations
- Q & A
Meet the Speakers
John Shakow. J.D. is a Counsel in the Washington, D.C. office of King & Spalding LLP. Mr. Shakow was the lead speaker on ePharmaceuticals’ first program on the proposed Medicaid Rebate Rule (click here for information). Mr. Shakow's practice is focused exclusively on the representation of pharmaceutical and biopharmaceutical manufacturers on regulatory and litigation issues related to drug pricing and price reporting, including day-to-day counseling, internal investigations, civil litigation and defense in government investigations.
Peter Claude, is a Partner in PricewaterhouseCoopers’ Pharmaceutical Advisory Services Group. Mr. Claude has led a number of domestic and international advisory and assurance engagements, including pharmacy benefit manager reviews, sales and marketing risk assessments, government price reporting methodology and process reviews, and Medicaid rebate process and accrual reviews.
Who Should Attend this Webcast?
Pharmaceutical companies and managed care organizations. Anyone who will be involved in complying with the new price reporting requirements will benefit from this program, but especially decision-makers from:
- Government affairs
- Legal
- Compliance
- Drug pricing
- Regulatory affairs
Program Materials
You will also presentation slides and other materials that you can print and distribute to all of your peers at your location.
Save money when you purchase multiple copies! Ask your customer service representative about money-saving
discounts and bulk orders. Call toll free 800-650-6787 or e-mail
customerservice@hcpro.com.
